These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2202127)

  • 1. Requirements for safe prednisone discontinuation in late renal transplantation in recipients immunosuppressed with cyclosporine.
    Lloveras J; Puig JM; Comerma I; Orfila A; Mir M; Masramón J; Aubia J
    Transplant Proc; 1990 Aug; 22(4):1693-4. PubMed ID: 2202127
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC; Sibley RK; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
    Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 5. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract]   [Full Text] [Related]  

  • 7. Consequences of conversion from cyclosporine to conventional therapy in renal transplantation.
    Abbud-Filho M; Barberato JB; Ramalho HJ; Saldanha LB; Casassanta DM; Denadai ER; Zerati S; Bezas AG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1638-40. PubMed ID: 2652535
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine to azathioprine conversion in cadaveric renal transplants.
    Gonwa TA; Nghiem DD; Corry RJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2018-20. PubMed ID: 3079068
    [No Abstract]   [Full Text] [Related]  

  • 9. A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone.
    Schweizer RT; Rovelli M; Roper L; Bartus SA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1944-6. PubMed ID: 3079062
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful cadaveric renal transplantation in infants and young children.
    Ettenger RB; Rosenthal JT; Marik J; Salusky IB; Kamil E; Malekzadeh MH; Fine RN
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1707-8. PubMed ID: 2652559
    [No Abstract]   [Full Text] [Related]  

  • 11. Triple drug therapy: an alternative regimen in renal transplantation.
    Henry ML; Sommer BG; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1920-1. PubMed ID: 3079059
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
    Maddux MS; Veremis SA; Pollak R; Mozes MF
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is cyclosporine indicated in HLA-identical renal transplant recipients?
    Sumrani N; Delaney V; Ding Z; Davis R; Butt K; Hong J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1239-40. PubMed ID: 1989199
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
    Cardella CJ; Harding ME; deVeber GA; Honey J; Cook GT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
    Ebel H; Lange H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved immunosuppression for heart transplantation.
    Bolman RM; Elick B; Olivari MT; Ring WS; Arentzen CE
    J Heart Transplant; 1985 May; 4(3):315-8. PubMed ID: 3916502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative immunosuppressive strategies in the management of recipients of living related renal transplants.
    Hodge E; Banowsky L; Novick A; Lewis R; Streem S; Steinmuller D; Holzmann J; McFarlin L; Graneto D; Medendorp SV
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1609-14. PubMed ID: 2652524
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged cyclosporine therapy to induce solid engraftment after renal transplantation.
    Weimar W; Versluis DJ; Wenting GJ; Derkx FH; Schalekamp MA; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1998-9. PubMed ID: 3274462
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine as treatment for corticosteroid-resistant rejection episodes in renal transplantation.
    Garcia VD; Goldani JC; Garcia CD; Cantisani GP; Losekann A; Messias A; Mattos DB; Vitola SP; Bianchini JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1643-5. PubMed ID: 2652537
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporin A (CsA) and azathioprine (Aza) overlap in renal allografts with impaired renal function.
    Castelao AM; Griñó JM; Sabaté I; Gilvernet S; Andres E; Sabater R; Alsina J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1540-1. PubMed ID: 2652497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.